A Rise in IPOs Revive Investments for the Global Pharma and Biotech Industry
Oncology, anti-infective drugs, and pharmaceutical contract laboratories attract the most investment thus far
05-Jun-2014 -
The heightened private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008-2010, witnessed a decline post-2010. However, the fall in deals was not uniform among the constituent sectors, with the pharmaceutical, biotechnology and ...
biotechnology
Frost & Sullivan
investments
+1